期刊文献+

妇科肿瘤卡铂化疗所致过敏反应的中国专家共识(2022年版) 被引量:2

China expert consensus on hypersensitivity reactions induced by carboplatin chemotherapy of gynecologic tumors in China(2022 Edition)
下载PDF
导出
摘要 铂类药物广泛应用于妇科恶性肿瘤的化疗。卡铂作为顺铂的衍生物,属于第二代铂类抗癌药,具有“等效、低毒”的特点。过敏反应是卡铂化疗过程中的常见并发症,严重急性过敏反应可危及患者生命。预防卡铂过敏、及时诊断并给予规范治疗,对于提高妇科肿瘤治疗效果、降低患者死亡风险具有重要意义。本共识的制定,旨在为妇科肿瘤医师提供借鉴和指引。 Platinum drugs are currently widely used in the chemotherapy of gynecological tumors.As a derivative of cisplatin,carboplatin is a second-generation platinum-based anticancer drug with the characteristics of "equipotency" and "low toxicity".Hypersensitivity reactions to carboplatin are common complications during its treatment,but acute severe hypersensitivity reactions can endanger the lives of patients.Therefore,prevention of carboplatin-induced hypersensitivity,timely diagnosis of hypersensitivity reactions and proper treatments are important to improve the overall efficacy of carboplatin antitumor therapy and to reduce the risk of mortality.Hence,here comes the consensus on hypersensitivity reactions induced by carboplatin chemotherapy of gynecologic tumors in China(2022 edition),aiming to provide guidelines for clinical practitioners and to standardize treatment behaviors.
作者 中国医师协会微无创医学专业委员会妇科肿瘤学组 张师前 邱晨 Gynecological Oncology Group,Minimally-invasive and Noninvasive Medicine Committee,Chinese Medical Doctor Association
出处 《肿瘤药学》 CAS 2022年第4期413-421,共9页 Anti-Tumor Pharmacy
关键词 妇科肿瘤 卡铂 过敏反应 治疗 预防 专家共识 Gynecologic oncology Carboplatin Hypersensitivity reaction Treatment Prevention Expert consensus
  • 相关文献

参考文献8

二级参考文献37

  • 1Ruth Gomez,Philipp Harter,Hans-Joachim Lück,Alexander Traut,Stefan Kommoss,Michaela Kandel,Andreas du Bois.Carboplatin Hypersensitivity: Does Introduction of Skin Test and Desensitization Reliably Predict and Avoid the Problem? A Prospective Single-Center Study[J].International Journal of Gynecological Cancer.2009(7)
  • 2A. GADDUCCI,R. TANA,G. TETI,G. ZANCA,A. FANUCCHI,A. R. GENAZZANI.Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer[J].International Journal of Gynecological Cancer.2008(4)
  • 3RonitConfino‐Cohen,AmiramFishman,MarcoAltaras,ArnonGoldberg.Successful carboplatin desensitization in patients with proven carboplatin allergy[J].Cancer.2005(3)
  • 4M. J. KANDEL,A. LOEHR,P. HARTER,A. TRAUT,K. GNAUERT,A. DU BOIS.Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity[J].International Journal of Gynecological Cancer.2005(5)
  • 5Werner J Pichler.Immune mechanism of drug hypersensitivity[J].Immunology and Allergy Clinics of North America.2004(3)
  • 6Margaret Markman,Kristine Zanotti,Barbara Kulp,Gertrude Peterson,Maurie Markman.Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity[J].Gynecologic Oncology.2003(3)
  • 7Don S. Dizon,Paul J. Sabbatini,Carol Aghajanian,Martee L. Hensley,David R. Spriggs.Analysis of Patients with Epithelial Ovarian Cancer or Fallopian Tube Carcinoma Retreated with Cisplatin after the Development of a Carboplatin Allergy[J].Gynecologic Oncology.2002(3)
  • 8Jubilee B. Robinson,Diljeet Singh,Diane C. Bodurka-Bevers,J.Taylor Wharton,David M. Gershenson,Judith K. Wolf.Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic Malignancies[J].Gynecologic Oncology.2001(3)
  • 9湿疹诊疗指南(2011年)[J].中华皮肤科杂志,2011,44(1):5-6. 被引量:490
  • 10曾凤伟,程木华.肾小球滤过率的测定方法及进展[J].新医学,2011,42(2):123-126. 被引量:11

共引文献445

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部